SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001048477-24-000110
Filing Date
2024-05-23
Accepted
2024-05-23 17:36:34
Documents
3
Period of Report
2024-05-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1716500181.html 4  
1 FORM 4 wk-form4_1716500181.xml 4 3162
2 EX-24 section16filingspowerofa.htm EX-24 3888
3 section16filingspowerofa001.jpg GRAPHIC 219215
  Complete submission text file 0001048477-24-000110.txt   310471
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Issuer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ALLERGAN 2525 DUPONT DRIVE IRVINE CA 92612
Business Address
PYOTT DAVID E I (Reporting) CIK: 0001051578 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26727 | Film No.: 24979867